Fiche publication


Date publication

janvier 2025

Journal

Journal of cellular and molecular medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LEHN Jean-Marie


Tous les auteurs :
Koj S, Niedziela T, Rossowska J, Schmitt JL, Lehn JM, Nicolau C, Kieda C

Résumé

The hypoxic microenvironment is crucial for tumour cell growth and invasiveness. Tumour tissue results from adaptation to reduced oxygen availability. Hypoxia first activates pro-angiogenic signals for alleviation. Pathologic, tumour angiogenesis maintains hypoxia, impairing treatment outcomes. Vessel normalisation requires physioxia. Oxygen delivery by red blood cell (RBC) carrying haemoglobin (Hb) is enhanced by myo-inositol trispyrophosphate (ITPP), an effector of oxygen transport by RBCs. Altering glycolytic activity, it lowers intracellular pH and increases oxygen release from Hb. P NMR tracking of 2,3-diphosphoglycerate (2,3-DPG), allosteric effector of Hb and non-penetrating anion in RBCs, reports on erythrocytes internal environment. P resonances of 2,3-DPG are pH-sensitive, their positions indicate the oxygenation state of RBCs and interactions with effectors such as ITPP. Here we show in vitro and in vivo, that modifying Hb activity through band-3 anion transporter, ITPP enhances oxygen release and controls RBC internal pH. Its blood availability validates applicability of ITPP-based strategies.

Mots clés

2,3‐diphosphoglycerate, 31P NMR, erythrocyte, hypoxia, myo‐inositol trispyrophosphate, oxygen, pH

Référence

J Cell Mol Med. 2025 01;29(2):e70343